baicalin has been researched along with Fatty Liver, Nonalcoholic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KT; Lai, YS; Nguyen, HT; Salmanida, FP | 1 |
| Chen, Y; Duan, Z; Gao, W; Liu, S; Xu, B; Zhang, X; Zhang, Y | 1 |
| Chen, Y; Huang, K; Lu, W; Qiao, F; Shi, H; Wen, Y; Ye, L | 1 |
| Fan, K; Gao, Y; Guo, J; Hao, Z; Li, H; Liu, J; Sun, N; Sun, P; Yin, W; Zheng, X | 1 |
| Chang, J; Guan, X; Liu, C; Liu, J; Mao, X; Shen, S; Song, H; Song, J; Zhang, L | 1 |
| Gong, X; Hu, J; Kuang, G; Liu, J; Wan, J; Wu, S; Yin, X; Yuan, Y; Zhang, L; Zhang, X; Zhou, Q | 1 |
| Chen, Y; Li, J; Liu, L; Qiao, F; Shi, H; Xing, J; Zhang, Y | 1 |
| Deng, X; Li, G; Liu, B; Xin, S; Xu, K; Zhang, H; Zhang, J; Zhang, N | 1 |
| Liu, H; Zhong, X | 1 |
9 other study(ies) available for baicalin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
MERTK
Topics: Adoptive Transfer; Animals; c-Mer Tyrosine Kinase; Cell Transplantation; Collagen Type I; Collagen Type I, alpha 1 Chain; Diet, High-Fat; Disease Models, Animal; Female; Flavonoids; Lipoproteins, HDL; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR gamma; Signal Transduction; T-Lymphocytes; Transcriptome; Treatment Outcome; Tumor Necrosis Factor-alpha | 2021 |
Baicalin Attenuates Oxidative Stress in a Tissue-Engineered Liver Model of NAFLD by Scavenging Reactive Oxygen Species.
Topics: Flavonoids; Humans; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Reactive Oxygen Species | 2022 |
Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Fatty Acids, Nonesterified; Liver; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; RNA, Small Interfering | 2022 |
Baicalin ameliorates high fat diet-induced nonalcoholic fatty liver disease in mice via adenosine monophosphate-activated protein kinase-mediated regulation of SREBP1/Nrf2/NF-κB signaling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Signal Transduction | 2023 |
Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway.
Topics: Animals; Caspase 1; Magnesium; Magnesium Sulfate; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction | 2023 |
Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice.
Topics: Animals; Choline Deficiency; Cytokines; Diet; Drug Liberation; Flavonoids; Liposomes; Liver; Male; Methionine; Mice, Inbred C57BL; Nanoparticles; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4 | 2020 |
Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis.
Topics: Down-Regulation; Drugs, Chinese Herbal; Flavonoids; Hep G2 Cells; Hepatocytes; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Liver; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Phosphate-Binding Proteins; Pyroptosis; Scutellaria baicalensis | 2020 |
Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Chemokine CCL2; Choline Deficiency; Diet; Flavonoids; Interleukin-1beta; Lipid Metabolism; Liver; Liver Cirrhosis; Liver Function Tests; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2018 |
Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Chemokine CCL2; Cyclooxygenase 2; Cytochrome P-450 CYP2E1; Diet; Flavonoids; Inflammation; Liver; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Tumor Necrosis Factor-alpha | 2018 |